Deidra C. Crews, MD, ScM, FASN, MACP
Professor of Medicine, Division of Nephrology
Deputy Director, Johns Hopkins Center for Health Equity
Director, Doctoral Diversity Program
Johns Hopkins University School of Medicine
Dr. Crews is a Professor of Medicine in the Division of Nephrology at the Johns Hopkins University School of Medicine. She holds appointments with the School of Nursing, the Welch Center for Prevention, Epidemiology and Clinical Research, the Center on Aging and Health, and the Center for Health Equity, where she is Deputy Director. Her research focuses on addressing disparities in the care and outcomes of kidney disease and hypertension. An elected member of the American Society for Clinical Investigation, Dr. Crews has received numerous awards for her research contributions, including the 2018 Johns Hopkins University President’s Frontier Award–a $250,000 award granted annually to a single faculty scholar on the cusp of transforming their field. She is a former National Academy of Medicine (NAM) Emerging Leader Scholar and was the inaugural Gilbert S. Omenn Anniversary Fellow of the NAM. Dr. Crews has previously received the W. Lester Henry Award for Diversity and Access to Care from the American College of Physicians (ACP) and is a Master of the ACP. The American Society of Nephrology (ASN) has previously honored Dr. Crews with its Distinguished Leader Award, and she was recently elected as an Executive Councilor of the ASN.
Dr. Crews received her undergraduate degree from the University of Virginia and her medical degree from Saint Louis University. A graduate of the Osler Medical Training Program, she completed nephrology fellowship and a master’s in clinical epidemiology degree at Johns Hopkins.
Josef Coresh, MD, PhD
G.W. Comstock Professor of Epidemiology, Biostatistics & Medicine, Johns Hopkins University
Director, George W. Comstock Center for Public Health Research & Prevention
Director, Cardiovascular Epidemiology Training Program
Dr. Josef Coresh is an international expert in kidney and cardiovascular disease epidemiology. He is the George W. Comstock Professor of Epidemiology, Biostatistics, and Medicine at Johns Hopkins University.
Dr. Coresh helped develop the globally adopted chronic kidney disease definition, staging, and estimated kidney function equations. He is a co-author on the 2021 update by the CKD-EPI collaboration which removed race from the GFR estimation equation. He co-leads the CKD Prognosis Consortium (CKD-PC) whose results based on over 80 cohorts and >10 million participants from 40+ countries have informed clinical practice guidelines, FDA, and EMA policies. Their risk equations can be found at ckdpcrisk.org.
Dr. Coresh co-authored over eight hundred research articles cited over 100,000 times. He received the top scientific and patient impact awards of the US National Kidney Foundation (Eknoyan and Hume awards) and the American Society of Nephrology (Belding Scribner award). His devotion to mentorship was recognized by awards from Johns Hopkins University and the American Heart Association.
Dr. Coresh is an international expert in kidney and cardiovascular disease epidemiology having co-authored over eight hundred research articles cited over 100,000 times. Each year since 2014 he was recognized as being among the top 1% of researchers in Clinical Medicine globally (by article citations). Among other awards, he received the top scientific and patient impact awards of the United States National Kidney Foundation (NKF Eknoyan and Hume awards) and American Society of Nephrology (ASN Scribner award).
Dr. Coresh was born in Israel and moved to Chicago when he was thirteen. Joe has a bachelor’s in mathematics from Princeton University followed by a combined M.D. and Ph.D. degree in epidemiology as well as a Masters in biostatistics from Johns Hopkins University. He stayed at Johns Hopkins where he directs the Cardiovascular Epidemiology Training Program and the George W. Comstock Center for Public Health Research and Prevention. His research portfolio is diverse following the blood vessels from the heart to the kidney and the brain with grants of over $5M/year focused on big data and molecular studies. His research spans a range of prospective and biomarker studies as well as a clinical trial for correction of hearing loss to delay cognitive decline. He leads the ARIC study at Johns Hopkins – a cohort of 16,000 participants followed since 1988. ARIC data are widely used and the publications committee he chairs approves proposals leading to over 150 peer-reviewed publications annually.